Management of hyponatremia.
作者信息
Lee Jennifer Ji Young, Kilonzo Kajiru, Nistico Amy, Yeates Karen
出版信息
CMAJ. 2014 May 13;186(8):E281-6. doi: 10.1503/cmaj.120887. Epub 2013 Dec 16.
Abstract
摘要
相似文献
1
Management of hyponatremia.低钠血症的管理
CMAJ. 2014 May 13;186(8):E281-6. doi: 10.1503/cmaj.120887. Epub 2013 Dec 16.
2
Letter: Vaptans for the treatment of hyponatraemia and ascites in patients with cirrhosis.信函：血管加压素受体拮抗剂用于治疗肝硬化患者的低钠血症和腹水
Aliment Pharmacol Ther. 2012 Dec;36(11-12):1103-4; author reply 1104. doi: 10.1111/apt.12081.
3
[Vasopressin receptor antagonists: the vaptans].[血管加压素受体拮抗剂：血管加压素受体拮抗剂类药物]
Endocrinol Nutr. 2010 May;57 Suppl 2:41-52. doi: 10.1016/S1575-0922(10)70021-8.
4
[Etiology, diagnostics and therapy of hyponatremias].[低钠血症的病因、诊断与治疗]
Orv Hetil. 2008 Jul 20;149(29):1347-54. doi: 10.1556/OH.2008.28409.
5
Vasopressin antagonists as aquaretic agents for the treatment of hyponatremia.血管加压素拮抗剂作为利水药用于治疗低钠血症。
Am J Med. 2006 Jul;119(7 Suppl 1):S87-92. doi: 10.1016/j.amjmed.2006.05.014.
6
The treatment of hyponatraemia using vasopressin antagonists.使用血管加压素拮抗剂治疗低钠血症。
Exp Physiol. 2000 Mar;85 Spec No:253S-257S. doi: 10.1111/j.1469-445x.2000.tb00030.x.
7
Therapeutic potential of vasopressin receptor antagonists.血管加压素受体拮抗剂的治疗潜力。
Drugs. 2007;67(6):847-58. doi: 10.2165/00003495-200767060-00002.
8
Therapeutic potential of vasopressin-receptor antagonists in heart failure.血管加压素受体拮抗剂在心力衰竭中的治疗潜力。
J Pharmacol Sci. 2014;124(1):1-6. doi: 10.1254/jphs.13r13cp. Epub 2014 Jan 7.
9
Vasopressin V2-receptor antagonists: panaceas for hyponatremia?血管加压素V2受体拮抗剂：低钠血症的万灵药？
Curr Opin Nephrol Hypertens. 1997 Sep;6(5):461-7. doi: 10.1097/00041552-199709000-00009.
10
Meta-analysis: the safety and efficacy of vaptans (tolvaptan, satavaptan and lixivaptan) in cirrhosis with ascites or hyponatraemia.荟萃分析：托伐普坦、索他普坦和利伐普坦在肝硬化伴腹水或低钠血症中的安全性和疗效。
Aliment Pharmacol Ther. 2012 Oct;36(7):619-26. doi: 10.1111/apt.12025. Epub 2012 Aug 21.
引用本文的文献
1
Point-of-care testing of hyponatremia and hypernatremia levels: An optoplasmonic biosensing approach.低钠血症和高钠血症水平的即时检测：一种光等离子体生物传感方法。
PLoS One. 2025 Apr 23;20(4):e0319559. doi: 10.1371/journal.pone.0319559. eCollection 2025.
2
Optimizing serum electrolyte levels in stroke patients: a multimodal approach with soymilk supplementation.优化中风患者的血清电解质水平：采用补充豆浆的多模式方法。
Ann Med Surg (Lond). 2024 Aug 6;86(9):5230-5237. doi: 10.1097/MS9.0000000000002390. eCollection 2024 Sep.
3
The syndrome of inappropriate antidiuresis: a diagnosis of exclusion for euvolemic hyponatremia.抗利尿激素分泌失调综合征：等容性低钠血症的排除性诊断。
Int Urol Nephrol. 2022 Aug;54(8):2093. doi: 10.1007/s11255-021-03097-x. Epub 2022 Jan 18.
4
Exploration of predictors of benefit from nivolumab monotherapy for patients with pretreated advanced gastric and gastroesophageal junction cancer: post hoc subanalysis from the ATTRACTION-2 study.探索纳武利尤单抗单药治疗预处理的晚期胃和胃食管交界处癌患者获益的预测因素：ATTRACTION-2 研究的事后亚分析。
Gastric Cancer. 2022 Jan;25(1):207-217. doi: 10.1007/s10120-021-01230-4. Epub 2021 Sep 4.
5
Successful Treatment with Percutaneous Balloon Kyphoplasty for Syndrome of Inappropriate Secretion of Antidiuretic Hormone Associated with Vertebral Compression Fracture: A Case Report.经皮球囊椎体后凸成形术治疗抗利尿激素分泌不当综合征相关的椎体压缩性骨折：病例报告。
Am J Case Rep. 2021 Mar 4;22:e928055. doi: 10.12659/AJCR.928055.
6
Perspectives From an Onconephrology Interest Group: Conference Report.肿瘤肾脏病学兴趣小组观点：会议报告
Can J Kidney Health Dis. 2020 Oct 15;7:2054358120962589. doi: 10.1177/2054358120962589. eCollection 2020.
7
Clinical utility of ultra-rapid whole-genome sequencing in an infant with atypical presentation of -associated nephrotic syndrome type 4.超快速全基因组测序在表现不典型的 4 型 -相关肾病综合征婴儿中的临床应用。
Cold Spring Harb Mol Case Stud. 2020 Aug 25;6(4). doi: 10.1101/mcs.a005470. Print 2020 Aug.
8
Reset Osmostat: Facts and Controversies.重置渗透压调节器：事实与争议
Indian J Nephrol. 2019 Jul-Aug;29(4):232-234. doi: 10.4103/ijn.IJN_307_17.
9
Hyponatremia during hospitalization and in-hospital mortality in patients hospitalized from heart failure.心力衰竭住院患者的住院期间低钠血症及院内死亡率
BMC Cardiovasc Disord. 2015 Aug 14;15:88. doi: 10.1186/s12872-015-0082-5.
本文引用的文献
1
Tolvaptan, an oral vasopressin antagonist, in the treatment of hyponatremia in cirrhosis.托伐普坦，一种口服血管加压素拮抗剂，治疗肝硬化伴低钠血症。
J Hepatol. 2012 Mar;56(3):571-8. doi: 10.1016/j.jhep.2011.08.020. Epub 2011 Oct 23.
2
An intervention study of oral versus intravenous hypertonic saline administration in ultramarathon runners with exercise-associated hyponatremia: a preliminary randomized trial.口服与静脉输注高渗盐水治疗超长马拉松运动员运动相关性低钠血症的干预研究：一项初步随机试验。
Clin J Sport Med. 2011 May;21(3):200-3. doi: 10.1097/JSM.0b013e31821a6450.
3
Effect of loading dose and formulation on safety and efficacy of conivaptan in treatment of euvolemic and hypervolemic hyponatremia.负荷剂量和剂型对血管加压素 V2 受体拮抗剂治疗等容量性和高容量性低钠血症安全性和疗效的影响。
Am J Health Syst Pharm. 2011 Apr 1;68(7):590-8. doi: 10.2146/ajhp100243.
4
Efficacy and safety of oral tolvaptan therapy in patients with the syndrome of inappropriate antidiuretic hormone secretion.口服托伐普坦治疗抗利尿激素分泌不当综合征患者的疗效和安全性。
Eur J Endocrinol. 2011 May;164(5):725-32. doi: 10.1530/EJE-10-1078. Epub 2011 Feb 11.
5
Short- and long-term treatment of dilutional hyponatraemia with satavaptan, a selective arginine vasopressin V2-receptor antagonist: the DILIPO study.使用选择性血管加压素 V2 受体拮抗剂 satavaptan 治疗稀释性低钠血症的短期和长期疗效：DILIPO 研究。
Eur J Heart Fail. 2011 Mar;13(3):327-36. doi: 10.1093/eurjhf/hfq226. Epub 2011 Jan 3.
6
Rationale and design of the treatment of hyponatremia based on lixivaptan in NYHA class III/IV cardiac patient evaluation (THE BALANCE) study.基于托伐普坦治疗心力衰竭伴低钠血症患者的评价（THE BALANCE）研究的原理和设计。
Clin Transl Sci. 2010 Oct;3(5):249-53. doi: 10.1111/j.1752-8062.2010.00217.x.
7
Management of hyponatremia: providing treatment and avoiding harm.低钠血症的管理：提供治疗并避免危害。
Cleve Clin J Med. 2010 Oct;77(10):715-26. doi: 10.3949/ccjm.77a.08051.
8
Use of Conivaptan (Vaprisol) for hyponatremic neuro-ICU patients.使用 Conivaptan（Vaprisol）治疗低钠血症神经 ICU 患者。
Neurocrit Care. 2010 Aug;13(1):57-61. doi: 10.1007/s12028-010-9379-5.
9
Vasopressin receptor antagonists for the treatment of hyponatremia: systematic review and meta-analysis.血管加压素受体拮抗剂治疗低钠血症：系统评价和荟萃分析。
Am J Kidney Dis. 2010 Aug;56(2):325-37. doi: 10.1053/j.ajkd.2010.01.013. Epub 2010 Jun 9.
10
Oral tolvaptan is safe and effective in chronic hyponatremia.口服托伐普坦治疗慢性低钠血症安全有效。
J Am Soc Nephrol. 2010 Apr;21(4):705-12. doi: 10.1681/ASN.2009080857. Epub 2010 Feb 25.
Zotero 插件